Rich list names hurt by cruel April for biotech stocks
In April almost $1 billion was wiped from the combined market value of four well-regarded companies: Acrux, Mesoblast, QrXPharma and Prana Biotechnology, dragging down equally well known names such as Waislitz and Liberman.
The portfolios of some of Australia’s richest investors have been battered by the terrible start to the year experienced by biotechnology stocks.
In April, almost $1 billion was wiped from the combined market value of four companies, Acrux , Mesoblast , QrXPharma and Prana Biotechnology , dragging down equally well known names like Waislitz, Liberman, Smorgon and Walker.
Subscribe to gift this article
Gift 5 articles to anyone you choose each month when you subscribe.
Subscribe nowAlready a subscriber?
Introducing your Newsfeed
Follow the topics, people and companies that matter to you.
Find out moreRead More
Latest In Healthcare & fitness
Fetching latest articles